Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001058379 | SCV001222945 | uncertain significance | not provided | 2022-08-22 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with cysteine, which is neutral and slightly polar, at codon 558 of the CNGB3 protein (p.Gly558Cys). This variant is present in population databases (rs749413012, gnomAD 0.04%). This missense change has been observed in individual(s) with achromatopsia or retinitis pigmentosa (PMID: 15712225). ClinVar contains an entry for this variant (Variation ID: 554831). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CNGB3 protein function. Experimental studies have shown that this missense change affects CNGB3 function (PMID: 26106334). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Myriad Genetics, |
RCV000670529 | SCV002060217 | uncertain significance | Achromatopsia 3 | 2021-11-10 | criteria provided, single submitter | clinical testing | NM_019098.4(CNGB3):c.1672G>T(G558C) is a missense variant classified as a variant of uncertain significance in the context of CNGB3-related achromatopsia. G558C has been observed in cases with relevant disease (PMID: 15712225, 28224992, 28005958). Functional assessments of this variant are available in the literature (PMID: 26106334). G558C has been observed in population frequency databases (gnomAD: AMR 0.04%). In summary, there is insufficient evidence to classify NM_019098.4(CNGB3):c.1672G>T(G558C) as pathogenic or benign. Please note: this variant was assessed in the context of healthy population screening. |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000678547 | SCV000804625 | uncertain significance | Retinitis pigmentosa | 2016-09-01 | no assertion criteria provided | clinical testing | |
Natera, |
RCV001272481 | SCV001454543 | uncertain significance | Achromatopsia | 2020-09-16 | no assertion criteria provided | clinical testing |